SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-263718
Filing Date
2022-10-17
Accepted
2022-10-17 16:02:39
Documents
14
Period of Report
2022-10-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385628d8k.htm   iXBRL 8-K 36804
2 EX-99.1 d385628dex991.htm EX-99.1 14117
6 GRAPHIC g385628dssp1.jpg GRAPHIC 7949
  Complete submission text file 0001193125-22-263718.txt   193084

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20221017.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20221017_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20221017_pre.xml EX-101.PRE 11257
8 EXTRACTED XBRL INSTANCE DOCUMENT d385628d8k_htm.xml XML 3399
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 221313797
SIC: 2834 Pharmaceutical Preparations